It is commonly perceived that the main obstacle for an effective partnership between Emergency Medicine (EM) and Laboratory Medicine (LM) is the lack of reciprocal knowledge and understanding. A further aspect is a partial comprehension of clinical significance and implications of some tests. The real scenario of attitudes and beliefs of Emergency Physicians (EPs) on lab tests utilization in clinical practice remains largely unclear. Therefore, this original study was designed to explore this field of medical knowledge, by using a survey on attitudes and beliefs in laboratory diagnostics which was disseminated among many Italian EPs. A questionnaire containing 20 different items/statements was designed and then disseminated either directly, or in a digital format. Overall, 183 questionnaires were compiled and collected. The results of this nationwide survey seem to confirm the existence of a suboptimal knowledge of both clinical and economic impact of urgent laboratory tests by Italian EPs. An unsatisfactory relation-ship between EPs and laboratory professionals seems also to emerge. Several EPs attribute this to Shortage of time to think (18.6%), followed by Fair of medical-legal litigation (13.6%). On the other hand, interestingly, it also emerged that some Italian hospitals still include obsolete o redundant tests in panels of urgent laboratory analyses, potentially misleading for the diagnostic reasoning in the Emergency Department (ED). In conclusion, the virtuous circle between EM and LM should be further reinforced for optimizing clinical pathways in Italian EDs, improving clinical outcomes and reducing unnecessary expenditures. A major agreement between laboratory and emergency professionals for harmonization of urgent test panels seems advisable.
Introduction
According to some published data, laboratory testing participates to the vast majority of clinical decisions. 1, 2 Since rapid and accurate diagnoses followed by appropriate treatments are the mainstays in the field of Emergency Medicine (EM), the Laboratory Medicine (LM) shall modulate its actual organization to fulfill these tasks and hence provide rapid and accurate tests that may allow Emergency Physicians (EPs) to make early rule out or rule in of most urgent and acute disorders. 3 Two Italian scientific societies of EM (Academy of Emergency Medicine and Care, AcEMC) and LM (Italian Society of Clinical Biochemistry and Clinical Molecular Biology, SIBioC) have been precursor for establishing a fruitful collaboration, with publication of many consensus documents on important topics such as panels of urgent diagnostic tests, 4, 5 diagnosing acute coronary syndrome, 6 sepsis, 7 and venous thromboembolism. 8 It is commonly perceived that a main obstacle for an effective partnership between EM and LM is the lack of sufficient reciprocal knowledge and understanding. A further aspect contributing to disrupt the liaison between EM and LM is an occasionally partial comprehension of clinical significance and implications of some tests. Notably, misconceptions and false myths are still exceptionally common in clinics, as comprehensively discussed elsewhere. 9, 10 In particular, appropriateness of test ordering remains a matter of major concern, whilst reliable evidence suggests that the panels of urgent tests are quite variegated, so highlighting a substantially unstandardized scenario. 9, 11, 12 A recent multicenter Spanish study, which has involved 36 hospitals, showed that the rate of stat tests requests was comprised between 44-412 per 1000 ED patient admissions. More importantly, the authors of this article also concluded that Spanish hospitals would have saved >1 million unnecessary tests by simply harmonizing the diagnostic approaches and establishing a favorable interdepartmental cooperation between EPs and laboratory professionals. 13 Despite some reliable guidance on appropriateness of laboratory test requests in the ED has been published by SIBioC, 14 then mutually agreed by both SIBioC and AcEMC, 4 the real scenario of attitudes and beliefs of EPs on lab tests utilization in clinical practice remains largely unclear. Therefore, this original study was designed to explore this field of medical knowledge, by using a survey on attitudes and beliefs in laboratory diagnostics which was disseminated among many Italian EPs.
Materials and Methods Design
A questionnaire containing 20 different items/statements (shown in the Appendix) was designed by a group of members of both national societies (AcEMC and SIBioC), which was then disseminated either directly (by a chief or senior physician), or in a digital format available on the AcEMC website to a large number of Italians EPs. The survey contained questions on inclination in requesting and managing laboratory medicine testing, specific knowledge on clinical meaning of some laboratory tests and/or profiles, and some economic and organizational implications of in vitro diagnostic testing. Some questions allowed a single response (e.g., yes or no), whilst others allowed multiple responses. All participants were informed that the questionnaire was anonymous, was only aimed for scientific purposes, and that participation was not mandatory.
Data collection
All responses were collected anonymously. In each of the 15 centers involved, a physician was responsible for distribution and collection of questionnaires, as well as for returning the surveys to the AcEMC administrative assistant. All the questionnaires compiled trough the digital platform were collected by one of the Authors (LB). The available period for compiling the questionnaires was comprised between February 1st and March 15th, 2019. After collection was concluded, both manual and digital questionnaires were pooled and analyzed altogether. The study was performed in agreement with the ethical standards established by the Helsinki Declaration of 1975. Due to the type of study, approval by ethic committee was not necessary (participation was open and free).
Results
Overall, 183 questionnaires were compiled and collected. Since not all the responders answered to all the 20 items, the sum of responses was <183 in some cases.
To the first statement Generally, when you order lab tests, 97 (53%) responders chose I only select the test I consider useful in that clinical presentation, whereas 86 (47%) chose I use standard panels. The answers to the second question (When you order lab tests do you think you often exceed, i.e., you order tests not addressed to that specific clinical presentation?) seem somewhat contradictory with the replies given to item n.1, since 120 (66%) responders selected Yes, whereas only 63 (34%) selected No. It seems rather obvious that choosing panels intrinsically means exceeding with number of tests. Even more surprising was the reply to the following statement ( Figure 1) . A total number of 122 responders selected No to the former question, whereas only 63 actually provided a response, as previously noted. Notably, more EPs believe that this may be attributable to Shortage of time to think (18.6%), than those who selected Fair of medical-legal litigation (13.6%). Figure 2 shows the replies to question n. 4 Figure 3 shows how the responders would be updated on new lab tests, displaying a large prevalence of Guidelines and recommendations (133/183).
Article
A total number of 133 (73.1%) responders selected Essential regarding the importance of the laboratory medicine in their clinical decisions, and 45 (24.7%) selecting Moderate, whilst only 2 selected the options Scarce or Nothing at all (2 EPs did not respond).
The multiple answers to question 9 highlight an important evidence of potential appropriateness, since in a considerable number of Italian hospitals some obsolete tests 15, 16 are still included in the emergency panels (Figure 4) .
When asked Which test do you consider the most important in influencing your clinical decisions?, nearly half of responders (89; 49%) selected cardiac troponin, followed by hematologic testing (47; 26%), and several others, as shown in Figure 5 . Surprisingly, when asked Which test could you quit among those available in your hospital?, some responders affirmed that they could renounce to lipase (3; 1.6%), and activated partial thromboplastin time (2; 1.1%). Then, when asked Which test do you wish to implement in emergency panels among those available in your hospital?, some responders replied that they would like to have lipase (4; 2.2%), ample toxicology panel (4; 2.2%), and white blood cell count (3; 1.6%), thus raising the legitimate question as why these essential tests are still unavailable in some facilities.
Regarding the expenditure for laboratory testing, only 10 responders (5.5%) replied that they knew exactly the costs of laboratory tests, whilst the vast majority of EPs affirmed that they were completely unaware (51; 27.9%) or only partially aware (122; 66.6%) of costs. The majority of responders to the following question (138; 75.4%) replied that urgent laboratory tests may account between 20-50% of the total volume of analyses performed in the local laboratory service, approaching the real-world data, as previously published. 17 Nevertheless, most responders substantially overestimated the real impact of laboratory expenditure on global hospital costs, whereby 120 responders (65.5%) replied 10% (59; 32.2%) and 25% (61; 33.3%), being the real value about 2-3%. 18 When asked In which percentage do you think that lab tests influence the clinical management of each patient, in general?, the vast majority of responders replied between 25-50% (55; 30%) and 50-75% (85; 46.5%). This is also in accordance with recent literature data, attesting that laboratory medicine would contribute to over 70% of clinical decisions. 1 The responders to the survey also emphasized that they wish to go deeper in this field of knowledge by better knowing the importance attributed to the single laboratory tests by available guidelines (132), as well as the diagnostic performance of the tests (85) (percentage is not provided, since multiple choices were allowed). Other responses are summarized in Figure 6 .
When asked In which diagnostic issues do you more frequently seek consultation with laboratory colleagues in test interpretation?, 88 responders (48.1%), replied I never seek consultation with laboratory colleagues. Among those who occasionally seek consultation with laboratory colleagues, the most frequent field was hematology (35), followed by diagnostics of acute myocardial infarction (22) and coagulation disorders (20) . When asked How could you describe your feedback from lab colleagues when you ask an expert opinion, the vast majority of responders replied that they find it useful (69: Almost always useful; 44: Sometimes useful). Finally, when asked Would you consider useful to be engaged in meeting shared between EM and LM?, 147 (84.9%) responders selected Yes.
Discussion
The results of this nationwide survey seem to confirm the existence of a suboptimal knowledge of both clinical and economic impact of urgent laboratory tests by Italian EPs. An unsatisfactory relationship between EPs and laboratory professionals seems also to emerge. On the other hand, it also interestingly emerged that some Italian hospitals still include obsolete o redundant tests in panels of urgent laboratory analyses (i.e., amylase, myoglobin, creatine kinase isoenzyme MB; aspartate aminotransferase), which would actually contribute to increase the costs without producing tangible clinical benefit or even possibly misleading the diagnostic reasoning in the ED. 15, 16 It has been convincingly demonstrated that the establishment of a virtuous circle between EM and LM would be essential for optimizing the use of human and technical resources in both environments, and is also necessary for improving clinical outcomes. 19, 20 Nevertheless, some major obstacles still challenge the establishment of this otherwise favorable liaison between EM and LM.
Defensive medicine is undoubtedly one of such issues, since the emergency settings are particularly plagued by malpractice and liability, 21 thus leading the way to an inappropriate utilization of laboratory resources. 22 This unjustified practice carries several risks, such as the possible generation of false positive results, the disruption of laboratory organization and ultimate waste of human and economic healthcare resources. 12 Previous evidence emphasized that the pattern of urgent test requesting in emergency settings is highly variable, 13 thus underscoring the need to achieve widespread consensus for harmonizing requesting attitudes. The data obtained with our survey ultimately confirm these findings.
The ED is a challenging environment, probably one of the most complicated in the healthcare industry, where clinical decisions must be rapidly taken for diagnosing or ruling diseases, and hence assuring the best managed care, preventing litigations and overcrowding. In this complex scenario, correct utilization of laboratory resources seems essential. There is widespread perception, occasionally supported by personal belief of some laboratory professionals, that diagnostic testing may be a foolproof instrument which can help diagnosing everything. Although both volume and quality of laboratory tests have enormously increased during the past decade, [23] [24] [25] no single test is capable to accurately define a healthy status, so that diagnostic testing only prescribed to satisfy patient's wishes should be eluded.
Although many physicians, including those working in the ED, have adequate knowledge of diagnostic implications of laboratory analyses, they frequently ignore the inherent drawbacks and limitations of such tests, especially for recently introduced biomarkers. These typically encompass technical and clinical aspects, which may ultimately derange the clinical efficiency of diagnostic testing. Although relatively infrequent, the results of some tests may then be occasionally unexpected or frankly contradictory with the patient status. Whenever biological causes can be ruled out, the more reasonable justification is a preanalytical error, such as misidentification, analysis of unsuitable specimens (for quality or quantity), as well as the presence of possible analytical interference due to the presence of rheumatoid factor, heterophilic antibodies, undue clots, etc. 26, 27 Although it is clearly unlikely that EPs can stay abreast of each single problem occurring during sample collection and handling, whenever test results conflict with clinical signs and symptoms, the effect of preanalytical variability shall always be investigated. In this setting, favorable collaboration between EM and LM will be effective to solve most of the problems and eventually detect the most likely cause for the bias. 
